# CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity

> **NCT01066728** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Manitoba** · enrollment: 87 (actual)

## Conditions studied

- Apnea of Prematurity

## Interventions

- **OTHER:** CO2 inhalation
- **DRUG:** Theophylline

## Key facts

- **NCT ID:** NCT01066728
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2005-09
- **Final completion:** 2007-03
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2010-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066728, "CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01066728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*